Industry Overview

Global multiplex assays market was valued at USD 2.79 Bn in 2020 and is expected to grow at a CAGR of 7.4% during 2021 – 2030 to reach XX Bn by the year 2030.

Introduction

The multiplex assays market Intelligence & research report cover in-depth analysis of the multiplex assays industry with a key focus on the global market trends, growth opportunities, market size (2020), market forecast 2030, key players Investment analysis by countries, significant industry development, etc. The report aims to provide an overview of the global multiplex assays market with detailed market division by type, component, by application, by source, and by regions. The multiplex assays market is projected to registered significant growth in specific profiled segments while other market segments are expected to witnessed declined in the revenue share over the forecasted period accounted for several influencing factors which are included in the report. The report provides industry status of the multiplex assays market players with market share, SWOT analysis, porter’s five force analysis, financial analysis & business strategy. The report focusses on providing data on growth opportunities, investment pockets, and regional analysis to leverage industry opportunities and gain competitive edge in the multiplex assays market.

Multiplex Assays Market Covid-19 Pandemic Impact & Recovery Analysis

The report focusses extensively on covid-19 pandemic impact on multiplex assays market across the globe. Major industry players implemented various business strategies to recover from this global challenge which are analyze in the report. COVID-19 pandemic short -term and long-term effects on multiplex assays market are provided in the report.

Leading companies in the multiplex assays market are expected to implement key business strategies along with portfolio diversification to gain competitive edge in the market. Business strategy with pre and post covid-analysis by key competitors is provided in detail in the competitive landscape mapping segment of the multiplex assays market report.

Multiplex Assays Market Segment Analysis

The report bifurcated multiplex assays market into key segments such as by product & services, by type, by technological, by application, by end-user and by regions, which represents global market. Market vendors across the globe in North America, Europe, Asia Pacific, Middle East & Africa, and South America are included in the report. Major factors that influence market growth in specific segment are analyze on Micro and Macro level.  The report also outlines some of the biggest development opportunities, market prediction, the introduction of the new products, and forecasting, numerous economic factors that are key in deciding the multiplex assays market pattern, market attractiveness and buying decisions.

Multiplex Assays Market Regional Analysis

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and South Americahttps://www.luminexcorp.com/. Country level analysis for each region is conducted to determine leading market region and identify future growth opportunities in various regions.

Competitive Insights

Companies in the multiplex assays market are bifurcated into leading, emerging and prominent players for competitive landscape mapping. Prominent players in the multiplex assays market are investing heavily in the mergers, acquisition, partnerships and research & development of the innovative products to gain larger market share.

Key market players (Direct & Indirect Competitors)

• Luminex Corporation
• Thermo Fisher Scientific Inc.
• Illumina, Inc
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Abcam plc
• Becton, Dickinson and Company
• Merck KGaA
• Agilent Technologies, Inc.
• Meso Scale Diagnostics
• Randox Laboratories
• Quanterix
• Bio-Techne Corporation
• Olink
• DiaSorin S.p.A.
• Seegene
• Promega Corporation
• Siemens Healthineers
• PerkinElmer, Inc.
• Shimadzu Biotech
• Antigenix America, Inc.
• Enzo Life Sciences, Inc.
• Boster Biological Technology
• AYOXXA Biosystems GmbH
• Cayman Chemical Company

Multiplex Assays Market Segmentation

The market intelligence & research report categorizes the multiplex assays market to forecast the revenues and analyze trends in each of the following subsegments:

• By Product & Services (Revenue, USD Million, 2016 – 2030)
  • Instruments
  • Consumables
  • Software and Services
• By Type (Revenue, USD Million, 2016 – 2030)
  • Protein Multiplex Assays
    • Planar Protein Assays
    • Bead-Based Protein Assays
    • Other Protein Assays
  • Nucleic Acid Multiplex Assays
    • Planar Nucleic Acid Assays
    • Bead-Based Nucleic Acid Assays
    • Other Nucleic Acid Assays
  • Cell-Based Multiplex Assays
• By Technology (Revenue, USD Million, 2016 – 2030)
  • Flow Cytometry
  • Fluorescence Detection
  • Luminescence
  • Multiplex Real-Time PCR
  • Other Technologies
• By Application (Revenue, USD Million, 2016 – 2030)
  • Research & Development
    • Drug Discovery & Development
    • Biomarker Discovery & Validation
  • Clinical Diagnostics
    • Infectious Diseases
    • Cancer
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Nervous System Disorders
    • Metabolism & Endocrinology Disorders
    • Other Diseases
• By End-User (Revenue, USD Million, 2016 – 2030)
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Research Institutes
  • Reference Laboratories
  • Other End Users
• By Region
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • South America
    • Brazil
    • Argentina